Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bryan Reasons Insider Profile
4 Followers
Bryan Reasons, CFO at Amneal Pharmaceuticals, holds 28.73K shares in Aclaris Therapeutics (Ticker: ACRS), holds 0.00 shares in Societal CDMO (Ticker: SCTL), holds 96.66K shares in Mallinckrodt public limited company (Ticker: MNKTQ).
Bryan Reasons Amneal Pharmaceuticals (AMRX)CFO
Amneal Pharmaceuticals (AMRX)
CFO
Not Ranked
Ranked #93,754 out of 98,042 Corporate Insiders
Bryan Reasons has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Bryan Reasons holds in companies
Most Profitable Insider Trade
Stock:
Mallinckrodt
(MNKKQ)
(MNKKQ)
Rating:Informative Buy
Date:Jun 07, 2019 - Jun 07, 2020
Return:-69.60%
The most profitable trade made by Bryan Reasons
Bryan Reasons's Trading History
Amneal Pharmaceuticals
May 08, 2018
CFO
Uninformative Sell
―
$0.00
Societal CDMO
Apr 08, 2024
―
Uninformative Sell
320.15K
$0.00
Aclaris Therapeutics
Jun 04, 2024
Director
Uninformative Buy
4.80K
$38.21K
Mallinckrodt
Jun 21, 2022
―
Uninformative Sell
―
$0.00
Mallinckrodt public limited company
Aug 18, 2023
―
Uninformative Sell
11.02K
$11.60K
List of latest transactions for each holding click on a transaction to see Bryan Reasons's performance on stock
You May Also Like
Bryan Reasons insider profile FAQ
What is the percentage of profitable transactions made by Bryan Reasons?
The percentage of profitable transactions made by Bryan Reasons is ―.
What is the average return per transaction made by Bryan Reasons?
The average return per transaction made by Bryan Reasons is ―.
What stocks does Bryan Reasons hold?
Bryan Reasons holds: AMRX, SCTL, ACRS, MNKKQ, MNKTQ stocks.
What was Bryan Reasons’s latest transaction?
Bryan Reasons latest transaction was an Uninformative Buy of $4.80K.
What was Bryan Reasons's most profitable transaction?
Bryan Reasons’s most profitable transaction was an Informative Buy of MNKKQ stock on June 7, 2019. The return on the trade was -69.60%.
What is Bryan Reasons's role in Amneal Pharmaceuticals?
Bryan Reasons's role in Amneal Pharmaceuticals is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.